2000
DOI: 10.1055/s-0037-1613976
|View full text |Cite
|
Sign up to set email alerts
|

Role of the Leucine-Rich Domain of Platelet GPIbα in Correct Post-translational Processing – The Nancy I Bernard-Soulier Mutation Expressed on CHO Cells

Abstract: SummaryThe mechanisms governing the biosynthesis and surface expression of platelet adhesive receptors on parent megakaryocytes are as yet poorly understood. In particular, the assembly and processing of the multisubunit glycoprotein (GP) Ib-IX-V complex, a receptor for von Willebrand factor (vWf) is not fully understood. In the present work, these questions were addressed by reproducing a natural mutation of GPIbα found in a variant case of Bernard-Soulier syndrome (Nancy I), due to the deletion of leucine 17… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 30 publications
1
17
0
Order By: Relevance
“…GPIba is also a receptor for thrombin. The integrity of the LRR domain of GPIb is essential for normal processing and function of the GPIb-IX complex [196]. BSS is an autosomal recessive bleeding disorder caused by genetic abnormalities in the GPIb-V-IX complex [195].…”
Section: Glycoprotein Iba (Gpiba) and Bernard-soulier Syndrome (Bss) mentioning
confidence: 99%
“…GPIba is also a receptor for thrombin. The integrity of the LRR domain of GPIb is essential for normal processing and function of the GPIb-IX complex [196]. BSS is an autosomal recessive bleeding disorder caused by genetic abnormalities in the GPIb-V-IX complex [195].…”
Section: Glycoprotein Iba (Gpiba) and Bernard-soulier Syndrome (Bss) mentioning
confidence: 99%
“…Mab WM23 against GPIbα was obtained from Dr Michael Berndt (Baker Medical Research Institute, Prahan, Victoria, Australia). Mab GS28 against GS28 (a specific cis-Golgi marker) was purchased from StressGen Biotechnologies Corp. (Victoria, BC, Canada), Mab CTR 433 (against an uncharacterized marker of the medial Golgi) and Mab Gi93 [against ER-to-Golgi intermediate compartments (ERGIC) marker] were obtained from Dr Michel Bornens (Institut Curie, Paris, France), and a polyclonal antibody against calnexin (an ER marker) was purchased from Chemicon, Temecula, CA, U.S.A. CHO cell lines expressing wild-type GPIbα associated with GPIbβ and GPIX (CHOαβIX) or expressing Leu"(*-deleted GPIbα associated with GPIbβ and GPIX (CHOα∆LeuβIX) have been described previously [20].…”
Section: Experimental Materialsmentioning
confidence: 99%
“…GPV was omitted on the basis of previous reports that it is not required for efficient expression of the complex [12,13]. The biosynthetic study was extended to a Bernard-Soulier mutant receptor characterized by a major defect in oligosaccharide processing and transport to the cell surface [20], despite normal synthesis and assembly of its three subunits. Results indicate that tight control is exerted at the exit to the endoplasmic reticulum (ER) and throughout passage through the Golgi structures, thus limiting the expression of abnormal complexes harbouring even subtle mutations on a single subunit.…”
Section: Introductionmentioning
confidence: 99%
“…Those described so far were all mutations of GPIbα: L57F (10), A156V (16), and L179 deletions (17). Those described so far were all mutations of GPIbα: L57F (10), A156V (16), and L179 deletions (17).…”
Section: Gpib-v-ix Complexmentioning
confidence: 87%